2020-03-06 最新期刊文獻

本日Medline新增46篇期刊文獻。其中一篇針對246名中國醫護人員的心理健康狀況進行的調查,發現近1/4醫護人員會產生焦慮,護理師焦慮比例又高於醫生,分析認為因為治療及護理等第一線工作多由護理師完成,與患者接觸更密切,再加上沒有適切的社會支持,因而焦慮程度較高(13)。另外在防疫方面,世衛組織估計每個月需要近9千萬個口罩來保護醫護人員面對COVID-19,但目前正迅速耗盡(21)。

  1. Al-Qaness MAA, Ewees AA, Fan H & Abd El Aziz M. (2020). Optimization Method for Forecasting Confirmed Cases of COVID-19 in China.  Journal of Clinical Medicine, 9, doi:10.3390/jcm9030674, https://doi.org/10.3390/jcm9030674 
  2. (2020). Coronavirus nixes conference, twilight zone beckons and a faded star brightens.  Nature, 579, 12-13. doi:10.1038/d41586-020-00589-1, https://doi.org/10.1038/d41586-020-00589-1 
  3. Bischof E, Chen G & Ferretti MT. (2020). Understanding COVID-19 new diagnostic guidelines - a message of reassurance from an internal medicine doctor in Shanghai.  Swiss Medical Weekly, 150, w20216. doi:10.4414/smw.2020.20216, https://doi.org/10.4414/smw.2020.20216 
  4. Cai SJ, Wu LL, Chen DF, Li YX, Liu YJ, Fan YQ, et al. (2020).正壓式頭罩的三級防護下新型冠狀病毒肺炎經支氣管鏡引導氣管插管12例臨床分析 [Analysis of bronchoscope-guided tracheal intubation in 12 cases with COVID-19 under the personal protective equipment with positive pressure protective hood].  Chung-Hua Chieh Ho Ho Hu Hsi Tsa Chih Chinese Journal of Tuberculosis & Respiratory Diseases, 43, E033. doi:10.3760/cma.j.cn112147-20200222-00153, https://doi.org/10.3760/cma.j.cn112147-20200222-00153 
  5. Cao Y, Li L, Feng Z, Wan S, Huang P, Sun X, et al. (2020). Comparative genetic analysis of the novel coronavirus (2019-nCoV/SARS-CoV-2) receptor ACE2 in different populations.  Cell Discovery, 6, 11. doi:10.1038/s41421-020-0147-1, https://doi.org/10.1038/s41421-020-0147-1 
  6. Chan JF, Kok KH, Zhu Z, Chu H, To KK, Yuan S, et al. (2020). Genomic characterization of the 2019 novel human-pathogenic coronavirus isolated from a patient with atypical pneumonia after visiting Wuhan.  Emerging Microbes & Infections, 9, 221-236. doi:10.1080/22221751.2020.1719902, https://doi.org/10.1080/22221751.2020.1719902 
  7. Chan JF, Yip CC, To KK, Tang TH, Wong SC, Leung KH, et al. (2020). Improved molecular diagnosis of COVID-19 by the novel, highly sensitive and specific COVID-19-RdRp/Hel real-time reverse transcription-polymerase chain reaction assay validated in vitro and with clinical specimens.  Journal of Clinical Microbiology, doi:10.1128/JCM.00310-20, https://doi.org/10.1128/JCM.00310-20 
  8. Cheng LT, Chan LP, Tan BH, Chen RC, Tay KH, Ling ML, et al. (2020). Deja Vu or Jamais Vu? How the Severe Acute Respiratory Syndrome Experience Influenced a Singapore Radiology Department's Response to the Coronavirus Disease (COVID-19) Epidemic.  AJR. American Journal of Roentgenology, 1-5. doi:10.2214/AJR.20.22927, https://doi.org/10.2214/AJR.20.22927 
  9. Cheng VCC, Wong SC, Chen JHK, Yip CCY, Chuang VWM, Tsang OTY, et al. (2020). Escalating infection control response to the rapidly evolving epidemiology of the Coronavirus disease 2019 (COVID-19) due to SARS-CoV-2 in Hong Kong.  Infection Control & Hospital Epidemiology, 1-24. doi:10.1017/ice.2020.58, https://doi.org/10.1017/ice.2020.58 
  10. Chua MSQ, Lee JCS, Sulaiman S & Tan HK. (2020). From the frontlines of COVID-19 - How prepared are we as obstetricians: a commentary.  BJOG: An International Journal of Obstetrics & Gynaecology, doi:10.1111/1471-0528.16192, https://doi.org/10.1111/1471-0528.16192 
  11. Diao M, Zhang S, Chen D & Hu W. (2020). The novel coronavirus (COVID-19) infection in Hangzhou: An experience to share.  Infection Control & Hospital Epidemiology, 1-5. doi:10.1017/ice.2020.62, https://doi.org/10.1017/ice.2020.62 
  12. Heymann DL, Shindo N & WHO Scientific and Technical Advisory Group for Infectious Hazards. (2020). COVID-19: what is next for public health?.  Lancet, 395, 542-545. doi:10.1016/S0140-6736(20)30374-3, https://doi.org/10.1016/S0140-6736(20)30374-3 
  13. Huang JZ, Han MF, Luo TD, Ren AK & Zhou XP. (2020).新型冠狀病毒肺炎定點收治醫院醫務人員心理健康調查 [Mental health survey of 230 medical staff in a tertiary infectious disease hospital for COVID-19].  Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi/Zhonghua Laodong Weisheng Zhiyebing Zazhi/Chinese Journal of Industrial Hygiene & Occupational Diseases, 38, E001. doi:10.3760/cma.j.cn121094-20200219-00063, https://doi.org/10.3760/cma.j.cn121094-20200219-00063 
  14. Jiang F, Deng L, Zhang L, Cai Y, Cheung CW & Xia Z. (2020). Review of the Clinical Characteristics of Coronavirus Disease 2019 (COVID-19).  Journal of General Internal Medicine, doi:10.1007/s11606-020-05762-w, https://doi.org/10.1007/s11606-020-05762-w 
  15. Kumar S, Poonam & Rathi B. (2020). Coronavirus Disease COVID-19: A New Threat to Public Health.  Current Topics in Medicinal Chemistry, doi:10.2174/1568026620999200305144319, https://doi.org/10.2174/1568026620999200305144319 
  16. Leeming J. (2019). Lessons learnt from doing research amid a humanitarian crisis.  Nature, 570, 547-549. doi:10.1038/d41586-019-01989-8, https://doi.org/10.1038/d41586-019-01989-8 
  17. Li F, Feng ZC & Shi Y. (2020). Proposal for prevention and control of the 2019 novel coronavirus disease in newborn infants.  Archives of Disease in Childhood Fetal & Neonatal Edition, doi:10.1136/archdischild-2020-318996, https://doi.org/10.1136/archdischild-2020-318996 
  18. Li Y & Xia L. (2020). Coronavirus Disease 2019 (COVID-19): Role of Chest CT in Diagnosis and Management.  AJR. American Journal of Roentgenology, 1-7. doi:10.2214/AJR.20.22954, https://doi.org/10.2214/AJR.20.22954 
  19. Li Y, Zhao R, Zheng S, Chen X, Wang J, Sheng X, et al. (2020). Lack of Vertical Transmission of Severe Acute Respiratory Syndrome Coronavirus 2, China.  Emerging Infectious Diseases, 26, doi:10.3201/eid2606.200287, https://doi.org/10.3201/eid2606.200287 
  20. Liu W, Zhu HL & Duan Y. (2020). Effective Chemicals against Novel Coronavirus (COVID-19) in China.  Current Topics in Medicinal Chemistry, doi:10.2174/1568026620999200305145032, https://doi.org/10.2174/1568026620999200305145032 
  21. Mahase E. (2020). Covid-19: hoarding and misuse of protective gear is jeopardising the response, WHO warns.  BMJ, 368, m869. doi:10.1136/bmj.m869, https://doi.org/10.1136/bmj.m869 
  22. Mei H & Hu Y. (2020). 新型冠狀病毒肺炎(COVID-19)患者出凝血功能障礙病因分析及診治策略 [Characteristics, causes, diagnosis and treatment of coagulation dysfunction in patients with COVID-19].  Chung-Hua Hsueh Yeh Hsueh Tsa Chih: Chinese Journal of Hematology, 41, E002. doi:10.3760/cma.j.issn.0253-2727.2020.0002, http://rs.yiigle.com/yufabiao/1183764.htm 
  23. Moorthy V, Henao Restrepo AM, Preziosi MP & Swaminathan S. (2020). Data sharing for novel coronavirus (COVID-19).  Bulletin of the World Health Organization, 98, 150. doi:10.2471/BLT.20.251561, https://doi.org/10.2471/BLT.20.251561 
  24. Ponce-de-Leon A, Galindo-Fraga A, Ruiz-Palacios GM & Sifuentes-Osornio J. (2020). WUHAN: BACK TO THE FUTURE AND THE RETURN OF CORONAVIRUSES.  Revista de Investigacion Clinica, 72, 5-7. doi:10.24875/RIC.20000023, https://doi.org/10.24875/RIC.20000023 
  25. Qiu YY, Wang SQ, Wang XL, Lu WX, Qiao D, Li JB, et al. (2020). 一起新型冠狀病毒肺炎家庭聚集性疫情的流行病學分析 [Epidemiological analysis on a family cluster of COVID-19].  Chung-Hua Liu Hsing Ping Hsueh Tsa Chih Chinese Journal of Epidemiology, 41, 506-509. doi:10.3760/cma.j.cn112338-20200221-00147, https://doi.org/10.3760/cma.j.cn112338-20200221-00147 
  26. Rothe C, Schunk M, Sothmann P, Bretzel G, Froeschl G, Wallrauch C, et al. (2020). Transmission of 2019-nCoV Infection from an Asymptomatic Contact in Germany.  New England Journal of Medicine, 382, 970-971. doi:10.1056/NEJMc2001468, https://doi.org/10.1056/NEJMc2001468 
  27. Rubin EJ, Baden LR & Morrissey S. (2020). Audio Interview: What Clinicians Need to Know in Diagnosing and Treating Covid-19.  New England Journal of Medicine, 382, e19. doi:10.1056/NEJMe2004244, https://doi.org/10.1056/NEJMe2004244 
  28. Scotti L & Scotti MT. (2020). China Coronavirus Outbreak: All the Latest Updates.  Current Topics in Medicinal Chemistry, doi:10.2174/1568026620999200305144537, https://doi.org/10.2174/1568026620999200305144537 
  29. Shanmugaraj B, Siriwattananon K, Wangkanont K & Phoolcharoen W. (2020). Perspectives on monoclonal antibody therapy as potential therapeutic intervention for Coronavirus disease-19 (COVID-19).  Asian Pacific Journal of Allergy & Immunology, doi:10.12932/AP-200220-0773, https://doi.org/10.12932/AP-200220-0773 
  30. Sigrist C, Bridge A & Le Mercier P. (2020). A potential role for integrins in host cell entry by SARS-CoV-2.  Antiviral Research, 104759. doi:10.1016/j.antiviral.2020.104759, https://doi.org/10.1016/j.antiviral.2020.104759 
  31. Wang H, Wang Z, Dong Y, Chang R, Xu C, Yu X, et al. (2020). Phase-adjusted estimation of the number of Coronavirus Disease 2019 cases in Wuhan, China.  Cell Discovery, 6, 10. doi:10.1038/s41421-020-0148-0, https://doi.org/10.1038/s41421-020-0148-0 
  32. Wang Y, Wang Y, Chen Y & Qin Q. (2020). Unique epidemiological and clinical features of the emerging 2019 novel coronavirus pneumonia (COVID-19) implicate special control measures.  Journal of Medical Virology, doi:10.1002/jmv.25748, https://doi.org/10.1002/jmv.25748 
  33. Wang YD, Zhang SP, Wei QZ, Zhao MM, Mei H, Zhang ZL, et al. (2020). 合併彌散性血管內凝血新型冠狀病毒肺炎(COVID-19)二例報導及文獻複習 [COVID-19 complicated with DIC: 2 cases report and literatures review].  Chung-Hua Hsueh Yeh Hsueh Tsa Chih: Chinese Journal of Hematology, 41, E001. doi:10.3760/cma.j.issn.0253-2727.2020.0001, http://rs.yiigle.com/yufabiao/1183765.htm 
  34. Wiffen P. (2020). Houston we have a problem: coronavirus!.  European Journal of Hospital Pharmacy Science & Practice, 27, 59. doi:10.1136/ejhpharm-2020-002240, https://doi.org/10.1136/ejhpharm-2020-002240 
  35. Wu WS, Li YG, Wei ZF, Zhou PH, Lyu LK, Zhang GP, et al. (2020). 天津市某百貨大樓新型冠狀病毒肺炎聚集性疫情調查分析 [Investigation and analysis on characteristics of a cluster of COVID-19 associated with exposure in a department store in Tianjin].  Chung-Hua Liu Hsing Ping Hsueh Tsa Chih Chinese Journal of Epidemiology, 41, 489-493. doi:10.3760/cma.j.cn112338-20200221-00139, https://doi.org/10.3760/cma.j.cn112338-20200221-00139 
  36. Xia W, Shao J, Guo Y, Peng X, Li Z & Hu D. (2020). Clinical and CT features in pediatric patients with COVID-19 infection: Different points from adults.  Pediatric Pulmonology, doi:10.1002/ppul.24718, https://doi.org/10.1002/ppul.24718 
  37. Xiao H, Zhang Y, Kong D, Li S & Yang N. (2020). The Effects of Social Support on Sleep Quality of Medical Staff Treating Patients with Coronavirus Disease 2019 (COVID-19) in January and February 2020 in China.  Medical Science Monitor, 26, e923549. doi:10.12659/MSM.923549, https://www.medscimonit.com/download/index/idArt/923549
  38. Yan R, Zhang Y, Li Y, Xia L, Guo Y & Zhou Q. (2020). Structural basis for the recognition of the SARS-CoV-2 by full-length human ACE2.  Science, doi:10.1126/science.abb2762, https://doi.org/10.1126/science.abb2762 
  39. Yang H, Wang C & Poon LC. (2020). Novel coronavirus infection and pregnancy.  Ultrasound in Obstetrics & Gynecology, doi:10.1002/uog.22006, https://doi.org/10.1002/uog.22006 
  40. Yi H. (2020). 2019 novel coronavirus is undergoing active recombination.  Clinical Infectious Diseases, doi:10.1093/cid/ciaa219, https://doi.org/10.1093/cid/ciaa219 
  41. Zheng M & Song L. (2020). Novel antibody epitopes dominate the antigenicity of spike glycoprotein in SARS-CoV-2 compared to SARS-CoV.  Cellular & Molecular Immunology, doi:10.1038/s41423-020-0385-z, https://doi.org/10.1038/s41423-020-0385-z (需訂閱)
  42. Zhou P, Huang Z, Xiao Y, Huang X & Fan XG. (2020). Protecting Chinese Healthcare Workers While Combating the 2019 Novel Coronavirus.  Infection Control & Hospital Epidemiology, 1-4. doi:10.1017/ice.2020.60, https://doi.org/10.1017/ice.2020.60 
  43. Zhou W, Liu Y, Tian D, Wang C, Wang S, Cheng J, et al. (2020). Potential benefits of precise corticosteroids therapy for severe 2019-nCoV pneumonia.  Signal Transduction and Targeted Therapy, 5, 18. doi:10.1038/s41392-020-0127-9, https://doi.org/10.1038/s41392-020-0127-9 
  44. Zhu WJ, Wang J, He XH, Qin Y, Yang S, Hu XS, et al. (2020).新型冠狀病毒肺炎疫情期間腫瘤患者肺部浸潤鑑別診斷  [The differential diagnosis of pulmonary infiltrates in cancer patients during the outbreak of the 2019 novel coronavirus disease].  Chung-Hua Chung Liu Tsa Chih [Chinese Journal of Oncology], 42, E008. doi:10.3760/cma.j.cn112152-20200303-00166, https://doi.org/10.3760/cma.j.cn112152-20200303-00166 
  45. Zhuang GH, Shen MW, Zeng LX, Mi BB, Chen FY, Liu WJ, et al. (2020). [Potential false-positive rate among the 'asymptomatic infected individuals' in close contacts of COVID-19 patients].  Chung-Hua Liu Hsing Ping Hsueh Tsa Chih Chinese Journal of Epidemiology, 41, 485-488. doi:10.3760/cma.j.cn112338-20200221-00144, (尚未刊登)
  46. Zumla A & Niederman MS. (2020). The explosive epidemic outbreak of novel coronavirus disease 2019 (COVID-19) and the persistent threat of respiratory tract infectious diseases to global health security.  Current Opinion in Pulmonary Medicine, doi:10.1097/MCP.0000000000000676, https://doi.org/10.1097/MCP.0000000000000676 (尚未刊登)



留言